Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Utilizing the Nu.Q®Vet Cancer Test in Practice: VMX 2026 presentation with Dr. Sue Cancer Vet

Thursday, January 22, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Volition has announced the submission of a manuscript for its Nu.Q® Vet Cancer Test in cats, which is expected to unlock a $5 million milestone payment upon publication. Additionally, the company has developed the first automated version of the test in collaboration with Fujifilm Vet Systems. These developments were highlighted in a presentation at VMX 2026 by Dr. Sue Cancer Vet.
Price reaction · baseline $5.83 (2026-01-21 close) · hit pre-market · 1 other VNRX headline(s) in the window, move may be shared
day 0 close · peak
-0.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Submission of manuscript for Nu.Q® Vet Cancer Test in cats could unlock funding.
  • First automated Nu.Q® Vet Cancer Test developed with Fujifilm Vet Systems.
  • Presentation at VMX 2026 highlights advancements in veterinary cancer testing.

Full Press Release Details

Related Articles

• Press Releases Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment
• Press Releases Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment

Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What is the Nu.Q® Vet Cancer Test?

The Nu.Q® Vet Cancer Test is a diagnostic tool designed to detect cancer in pets.

What milestone payment is associated with the Nu.Q® Vet Test?

The publication of the manuscript for the Nu.Q® Vet Cancer Test in cats may unlock a $5 million milestone payment.

Who presented at VMX 2026 regarding the Nu.Q® Vet Test?

Dr. Sue Cancer Vet presented information about the Nu.Q® Vet Cancer Test at VMX 2026.

What collaboration was announced with Fujifilm Vet Systems?

Volition announced the development of the first automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare Nu.Q® Vet cancer test Fujifilm Vet Systems VMX 2026
Last updated: Jan 22, 2026

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk